Kenneth Gouin

Kenneth Gouin is a Principal Bioinformatics Scientist I at Roche, with prior experience at Singular Genomics, where roles included Sr. Staff Scientist and various other positions in bioinformatics from July 2021 to November 2025. Kenneth's academic background includes a PhD in Biomedical Sciences and Translational Medicine from Cedars-Sinai Medical Center, where research focused on understanding therapeutic responses in triple negative breast cancer, particularly through single-cell RNA-sequencing. Previous roles at Capricor Therapeutics involved process development for exosome-based products, and earlier research at Cal Poly San Luis Obispo involved innovative methodologies in microvascular blood flow analysis. Kenneth holds a Master's and Bachelor's degree in Bioengineering and Biomedical Engineering from the same institution.